Ramaswamy Govindan,MD

Ramaswamy Govindan,MD

Medical Oncologist

Primary Academic Title

Anheuser Busch Endowed Chair in Medical Oncology, Professor of Medicine, Division of Oncology and Director, Section of Medical Oncology, WashU Medicine

Clinical Expertise

As the Anheuser Busch Endowed Chair in Medical Oncology and a member of our esophageal and lung cancer specialist teams, Dr. Govindan cares for patients diagnosed with these cancers through treatment and recovery.

Research Interest

The management of lung cancer, mesothelioma and esophageal cancer as well as developing clinical trials for patients with non-small cell lung cancer.

Education

  • 1986: MD, University of Madras, Madras, India

Training

  • 1987 - 1991: Resident,internal medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India
  • 1991 - 1993: Intern and resident, internal medicine, Michael Reese Hospital and Medical Center, Chicago
  • 1993 - 1996: Fellow, hematology and oncology, Washington University, St. Louis

Board Certification

  • 1993: American Board of Internal Medicine, Internal Medicine
  • 1996: American Board of Internal Medicine, Hematology
  • 1997: American Board of Internal Medicine, Medical Oncology

Selected Research Publications

Germline alterations in patients with lung cancer.
  • Govindan R, Navo K, Huang M, [...] Cao Y
  • Ann Oncol 2026
Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma.
  • Wang Y, Rosell R, Hirsch FR, [...] Govindan R, [...] Zhang JJ
  • Ann Oncol 2026
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer.
  • Ireland AS, Xie DA, Hawgood SB, [...] Govindan R, [...] Oliver TG
  • Nature 2025
Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute-Designated Cancer Center.
  • Tohmasi S, Baker TB, Heiden BT, [...] Govindan R, [...] Chen LS
  • J Natl Compr Canc Netw 2025
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures.
  • Satpathy S, Clark NM, Chen YJ, [...] Govindan R, [...] Gillette MA
  • Cancer Cell 2025
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.
  • Wang Y, Safi M, Hirsch FR, [...] Govindan R, [...] Zhang JJ
  • Nat Rev Clin Oncol 2025
Novel Therapies in Cancer: Trials and Tribulations.
  • Waqar SN, Govindan R
  • Clin Cancer Res 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.
  • Bulle A, Liu P, Seehra K, [...] Govindan R, [...] Lim KH
  • Nat Commun 2024

View All Publications

Contact Information

  • Gary C. Werths Building at Siteman Cancer Center

    4500 Forest Park Avenue
    Saint Louis, MO 63108

Phone Numbers

Request an appointment